These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Development and introduction of inactivated poliovirus vaccines derived from Sabin strains in Japan. Shimizu H Vaccine; 2016 Apr; 34(16):1975-85. PubMed ID: 25448090 [TBL] [Abstract][Full Text] [Related]
4. Polio vaccines and polio immunization in the pre-eradication era: WHO position paper. Wkly Epidemiol Rec; 2010 Jun; 85(23):213-28. PubMed ID: 20545051 [No Abstract] [Full Text] [Related]
5. The most ambitious vaccine introduction in history. Miller E Vaccine; 2014 Aug; 32(36):4599-601. PubMed ID: 24984120 [No Abstract] [Full Text] [Related]
6. Polio eradication in India: how far are we from reaching the goal? Banerjee K; Sahu S; Bandyopadhyay S Indian J Pediatr; 2001 Mar; 68 Suppl 1():S6-14. PubMed ID: 11411387 [No Abstract] [Full Text] [Related]
7. Risk management in a polio-free world. Bruce Aylward R; Sutter RW; Cochi SL; Thompson KM; Jafari H; Heymann D Risk Anal; 2006 Dec; 26(6):1441-8. PubMed ID: 17184391 [TBL] [Abstract][Full Text] [Related]
8. Cost analysis of post-polio certification immunization policies. Sangrujee N; Cáceres VM; Cochi SL Bull World Health Organ; 2004 Jan; 82(1):9-15. PubMed ID: 15106295 [TBL] [Abstract][Full Text] [Related]
9. [Problems of prevention and control of poliomyelitis in Poland]. Mazurowska-Magdzik W; Bucholc B; Janaszek-Seydlitz W; Szkoda T; Magdzik W Przegl Epidemiol; 2010; 64(3):341-7. PubMed ID: 20976944 [TBL] [Abstract][Full Text] [Related]
10. World could be declared free of polio by 2018. Gulland A BMJ; 2013 Apr; 346():f2373. PubMed ID: 23585234 [No Abstract] [Full Text] [Related]
11. On reducing the risk of vaccine-associated paralytic poliomyelitis in the global transition from oral to inactivated poliovirus vaccine. Peng X; Hu X; Salazar MA Lancet; 2018 Aug; 392(10147):610-612. PubMed ID: 29605427 [No Abstract] [Full Text] [Related]
12. The natural history of poliomyelitis in Israel, 1949-1982. Goldblum N; Swartz T; Gerichter CB; Handsher R; Lasch EE; Melnick JL Prog Med Virol; 1984; 29():115-23. PubMed ID: 6366916 [No Abstract] [Full Text] [Related]
13. Role of EIPV in 1988 Israel polio outbreak. Slater PE Vaccine; 1993 Sep; 11(12):1269. PubMed ID: 8256508 [No Abstract] [Full Text] [Related]
14. [Worldwide eradication of poliomyelitis]. Rasch G; Schreier E; Kiehl W; Kurth R Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120 [TBL] [Abstract][Full Text] [Related]
15. Poliomyelitis vaccines in Belgium: 20 years of experience. Andre FE Dev Biol Stand; 1979; 43():187-93. PubMed ID: 230109 [No Abstract] [Full Text] [Related]
16. [On the viability of introducing the inactivated polio vaccine in Colombia]. Alvarez FP; Mojica JA; Espinal C; Debbag R Rev Panam Salud Publica; 2011 May; 29(5):383-4; author reply 384-6. PubMed ID: 21709946 [No Abstract] [Full Text] [Related]
17. Stopping a polio outbreak in the post-eradication era. Fine PE; Sutter RW; Orenstein WA Dev Biol (Basel); 2001; 105():129-47; discussion 149-50. PubMed ID: 11763322 [No Abstract] [Full Text] [Related]
18. Combined use of inactivated and oral poliovirus vaccines in a large-scale campaign in refugee camps and host communities – Kenya, December 2013. Wkly Epidemiol Rec; 2014 Mar; 89(12):127-32. PubMed ID: 24707518 [No Abstract] [Full Text] [Related]
19. Poliomyelitis in the United States: the final chapter? Modlin JF JAMA; 2004 Oct; 292(14):1749-51. PubMed ID: 15479943 [No Abstract] [Full Text] [Related]